About company

Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, the drug candidate FOL-014 has demonstrated an increase in insulin release in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Aktietorget since 2014. www.follicum.com.

  • Listing Date 11/25/2014
  • Organisations number 556851-4532
  • Articles of association
  • Company presentation Company Presentation (video)
  • CEO Jan Alenfall
  • Chairman Fredrik Buch
  • Board Lars Bruzelius Fredrik Buch Anna Hultgårdh Nilsson Elisabeth Svanberg
  • LEI 967600Z7F0A07RKPMN97

Instrument Information

  • Share name Follicum
  • Short name FOLLI
  • Number of stocks 28 121 566
  • ISIN Code SE0006288270
  • OrderBookID 412P
  • CFI (ISO 10962) ESVUFR
  • FISN (ISO 18774) FOLLICUMAB/SH
  • Liquidity Provider Sedermera Fondkommission
  • Ratio value 0.12
  • First Traded 25-11-2014
  • Type Share

Other instrument from company

Name ISIN

Contact

Major share holders

According to Holdings**

Name Date Capital % Votes %
Avanza Pension 31-03-2018 10.36 10.36
Swedish Growth Fund 31-03-2018 10.3 10.3
Mats Lundberg 31-03-2018 3.3 3.3
Kudu AB 31-03-2018 2.59 2.59
Stiftelsen Akademihemman 31-03-2018 2.25 2.25
Nordnet Pensionsförsäkring 31-03-2018 1.91 1.91
Atherioco AB 31-03-2018 1.81 1.81
Tibia Konsult AB 31-03-2018 1.77 1.77
Pontus Dunér 31-03-2018 1.69 1.69
Brushamn Invest AB 31-03-2018 1.62 1.62

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.